U.S. health agencies to study heart risks of ADHD drugs

09/17/2007 | Reuters

The FDA is poised to work with the Agency for Healthcare Research and Quality on a study of the potential heart risks posed by drugs used in treating attention deficit hyperactivity disorder, health officials announced Monday. The two-year study will look into medical records of approximately 500,000 children and adults who have taken ADHD drugs, such as Ritalin and Adderall, which can increase heart rate and blood pressure in patients.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA